completed
Mar 14, 2023
ICAP worked in close collaboration with the CDC and the National Institute of Health (INS) to strengthen Mozambique’s national disease surveillance system. ICAP supported INS efforts to strengthen infection prevention and control (IPC) measures, coupled with disease...
Mar 13, 2023
Through a special gift from Dr. Bing Zhao, ICAP provided direct support to the COVID-19 response in Nampula province through the secondment of additional staff to increase the capacity of provincial and district health directorates. Through this support, ICAP provided...
Mar 12, 2023
ICAP is undertook a cross-sectional facility-based SARS-CoV-2 prevalence study to assess and estimate the prevalence of symptomatic and asymptomatic SARS-CoV-2 infection among children five years and older and adults in health facilities in Malawi. Fourteen health...
Mar 11, 2023
This randomized, double-blind, placebo-controlled multicenter study investigated the AstraZeneca (AZD1222) vaccine to prevent COVID-19 Closed to enrollment, follow up ongoing Web Links:...
Mar 10, 2023
Study to Assess the Efficacy and Safety of Ad26.COV2.S (the Johnson & Johnson COVID vaccine) for the Prevention of SARS-COV-2 mediated COVID-19 in Adults Aged 18 Years and Older Closed to enrollment and study follow-up Web Links:...